Company / Income Tax
KIORA PHARMACEUTICALS INC Income Tax History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$2.1M
FY2025
5-year range
$12.1K / $2.1M
FY2021-FY2025
Trend
+2186.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax changed +2186% YoY in FY2025, a notable deviation from the 5-year average annual change of +573%.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +85.0%.
Increased from $12,055 to $2M over the past 4 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +85.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +85.0%, indicating consistent growth.
- In FY2025, income tax increased 2186.3% year-over-year.
- Lowest income tax in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -5.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.1M | +2186.3% |
| FY2024 | $90.3K | +649.2% |
| FY2021 | $12.1K | -87.4% |
| FY2020 | $95.4K | +10.9% |
| FY2019 | $86.0K | +106.4% |
| FY2018 | -$1.3M | - |
| FY2017 | $0 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026